PowerPoint Presentation (PDF) - Perfusion.com

More documents

Recommendations

Info

ECHO: DAY 3 OF ECMO • Concentric left ventricular hypertrophy • Increased wall thickness • Increased myocardial mass index • Severe global hypokinesis of the LV • EF= 26%.
Page 1 and 2: A CASE REPORT: ECMO SUPPORT FOR FUL
Page 3 and 4: MYOCARDITIS: DEFINITION • Myocard
Page 5 and 6: CLASSIFICATION • Etiology • Ex:
Page 7 and 8: Phase I: Viral Infection • Cardio
Page 9 and 10: PHASE III: CELL-MEDIATED IMMUNITY
Page 11 and 12: FIGURE 1 PATHOGENESIS OF VIRAL MYOC
Page 13 and 14: HISTORY & PHYSICAL • 24 year old
Page 15: ICU AND RIGHT HEART CATH • VTach
Page 19 and 20: MUSC-ECMO •Equipment: •Stockert
Page 21: • Cardiac Stun: ECHO: DAY 1 OF EC
Page 27 and 28: ECHO: DAY 7 OF ECMO • EF= 55% •
Page 29 and 30: Cardiac Index (l/min/m²) 1 9 17 25
Page 31: DISCHARGE • 8 days S/P ECMO ECHO:
Page 36 and 37: Day 1 on ECMO Discharge
Page 38 and 39: FULMINANT: DEFINITION • Fulminant
Page 40 and 41: • FM: FM VS ACUTE • Fever and s
Page 42 and 43: FM VS ACUTE Cardiac Test Fulminant
Page 44: Fulminant Normal Cardiac Muscle Acu
Page 48 and 49: MECHANICAL CIRCULATORY SUPPORT FOR
Page 50 and 51: ADVANTAGES OF ECMO VS. VAD AS FIRST
Page 53 and 54: QUESTIONS??
Page 55 and 56: Two-dimensional echocardiograms fro
Page 57 and 58: This study demonstrated that 70% of
Page 59 and 60: • Myocardial Stunning and Hiberna
Page 61 and 62: MAJOR ETIOLOGICAL CLASSIFICATIONS O
Page 63 and 64: SUGGESTED GUIDELINES FOR CASE REPOR
Page 65: ABSTRACT Title: A case report: ECMO

PowerPoint Presentation (PDF) - Perfusion.com

Create successful ePaper yourself

Delete template?

Save as template?